- Significance of TCGA molecular classification in fertility-sparing treatment of endometrial cancer and atypical hyperplasia
-
Yiqin W, Nan K, Liwei L, Zhiqi W, Rong Z, Danhua S, Jianliu W
- KMID: 2537919
- J Gynecol Oncol.
- 2022 Aug;33(S1):S10.
- doi: 10.3802/jgo.2022.33.S10
Objective To investigate The Cancer Genome Atlas (TCGA) molecular classification of endometrial cancer (EC) and endometrial atypical hyperplasia (AH) treated with fertility-sparing therapy. Methods A total of 46 EC and AH patients who... -
- CITED
-
- Close
- SHARE
-
- Close
